Shared under ten

You can follow our portfolio and take advantage of it. Our portfolio is not a buy recommendation.

Analysis: Speculating on the breakthrough of cultured meat

The English investment company Agronomics participates in companies that are involved in sustainable food. There are more than twenty interests in the portfolio, including two Dutch.
The focus is on cultivated meat and the production of vegetarian proteins, oils and fats through precision fermentation. The production costs are the biggest obstacle to the breakthrough of cultivated meat.

When Maastricht professor Mark Post showed the world the very first artificially cultivated hamburger in 2013, the production costs were the equivalent of about $1 million per kilo. However, the costs are decreasing exponentially, so that market experts estimate that cultivated meat will reach a market share of 10% as early as 2030. Because Agronomics is currently trading at a discount of almost 35% to its net asset value, it is now possible to speculate on this promising, sustainable sector at an attractive discount.

Graph 1: Agronomics share price development in English pence over the past two years.

The market for cultured meat and vegetarian meat

Conventional food production is responsible for a staggering 26% of global greenhouse gas emissions, which is more than all forms of transportation combined. Large parts of the Amazon and other rainforests have been cleared for cattle ranching and soy production. There are therefore many gains to be made with sustainable solutions for food production. Table 1 shows that the sustainable production of vegetarian meat substitutes and cultivated meat requires up to 50% less energy compared to traditional meat production. Greenhouse gas emissions can be reduced by 90% to 97%, up to 99% of drinking water can be saved and only a fraction of the land currently used for traditional livestock farming is needed. In addition to these clearly quantifiable benefits, there are other benefits, such as preventing animal suffering, reducing the use of antibiotics and preventing epidemics.

Table 1: Overview of consumption of vegetarian meat (precision fermentation) and cultured meat compared to conventional meat.

Due to the numerous advantages that vegetarian and cultured meat offer in combination with a rapid decrease in costs, it is expected that their respective market shares will increase rapidly at the expense of conventional meat. This can be seen in Table 2. The market share of vegetarian meat substitutes will increase from 10% in 2025 to 25% in 2040. The market share of cultured meat will increase even faster; from 10% in 2030 to as much as 35% in 2040. The potential for vegetarian meat substitutes and cultured meat is therefore enormous.

Table 2: Market share of conventional, vegetarian and cultured meat from 2025 to 2040.

Cultured meat & vegetarian proteins

As already mentioned, Agronomics focuses on companies that are active as developers and producers of cultivated meat and of vegetarian proteins, oils and fats. With cultivated meat, the process is as follows: stem cells are isolated from a biopsy of an animal and with the help of a growth medium, oxygen and water, the stem cells multiply into a piece of meat. This is therefore not a meat substitute, because with the same building blocks, cultivated meat is identical to conventional meat. The vegetarian proteins, oils and fats are obtained by precision fermentation, or the stimulation of genetically modified bacteria and fungi.

The portfolio

Table 3 shows an overview of the portfolio. In addition to the activities just mentioned, there are also interests in cultivated leather, cultivated seafood, cultivated cotton and cultivated cocoa. There are two Dutch interests: Mosa Meat and Meatable. Mosa Meat is the Maastricht-based start-up founded by the aforementioned Mark Post and Meatable in Delft was founded by Daan Luining, among others. Mosa Meat in particular has received a lot of publicity due to the support of Sergey Brin, one of the founders of Google, among others. The founder of Thuisbezorgd, Jitse Groen, and Leonardo DiCaprio are also shareholders in Mosa Meat.

Table 3: overview of interests.

Results

Please note: the financial years are broken and run from 1 July to 30 June.
Table 4 shows the results from 2019 onwards. The turnover is formed by realised and unrealised profits and losses, so that it is in fact about the value development of the portfolio interests. Given that there has been a lot of interest in sustainably produced food in recent years, it is not surprising that the value development of the portfolio has been favourable in the past period.

Table 4: annual figure development.

The financial position

Table 5 shows that the company is debt free. The cash position is generous at £29.3m. There are no intangible assets, which means that the equity of £160.2m is equal to the net asset value (NAV), or 16.1p per share. The balance sheet is certainly solid.

Table 5: Balance sheet as of March 31, 2023.

Potential dilution, nearly 440 million warrants

There are almost 440 million warrants outstanding, which could mean significant dilution on the total number of outstanding shares of around 992 million. A closer look shows that 297 million warrants have an exercise price of 28.5 pence and an expiry date of 1 June 2024. In addition, 137 million other warrants have an exercise price of 30 pence and an expiry date of 8 December 2024. Given that the current price is barely 10 pence, this dilution will only come into play if the price increases by more than 200%.

Potential dilution, nearly 440 million warrants

The world of sustainable food production is similar to that of biotechnology. It revolves around intellectual property that is well protected and, as in biotechnology, it is difficult to predict which company will be successful. Agronomics seems to have found a nice formula by choosing a portfolio of around twenty interests with a team of sector specialists, which significantly reduces the risk in this speculative sector. With the successful British investor Jim Mellon on board, who not only has a stake of over 15% but is also part of the executive management, Agronomics has a heavyweight on board.

The opportunity to enter with a discount of around 35% on the NAV seems like a golden opportunity. Investors should keep in mind that despite the good diversification of interests in the portfolio, an investment in Agronomics is speculative. On the other hand, very high price gains are possible if one or more interests prove to be successful.

Key Facts
Name: Agronomics Limited
Ticker: ANIC
Exchange: London Stock Exchange (LSE)
ISIN: IM00B6QH1J21
Price: 10.5 pence
52-week low: 9.6 pence
52-week high: 20.5 pence
Price GBP.USD: 1.2370
Number of shares outstanding: 992 million
Market capitalisation: £104.2 million
Cash position: £29.3 million
Total debt: nil
Net worth: £29.3 million
Enterprise value (EV): £74.9 million
Net asset value (NAV): £160.2 million
NAV per share: 16.1 pence
Price/NAV: 0.65x
Dividend per share: 0.0 pence

Major Shareholders
Jim Mellon: 15.4%
Hargreaves Lansdown: 8.7%
BlackRock Inc: 6.3%
Canaccord Genuity: 5.8%
Interactive Investor Services: 5.1%
JPMorgan Chase Bank: 4.0%
Jupiter Asset Management: 2.6%

Website
www.agronomics.im

Verder lezen?

Dit artikel is alleen voor abonnees van Aandelen Onder Een Tientje. Indien u nog geen abonnee bent, overweegt u dan ook een abonnement.

Join thousands of others?

Become a member now and get instant access to our entire platform. 

The value we offer:

Lees ook

No posts found!

Analyse

We jump on the moving train…!

Yesterday we saw Avantium shares bounce back after a buy recommendation was issued. We are not hesitating, but are jumping on the train that has just started moving. The share has suffered greatly due to a large issue in which approximately €70 million was raised. Investors were disappointed and the price has collapsed! But what investors are overlooking in their frustration is that Avantium’s management has raised more than enough capital to finish their flagship, the FDCA factory in Delfzijl.  A number of very large companies have committed to purchasing the promising bioplastic or to producing it under license. This indicates that this is a potentially groundbreaking product. The share is trading almost at its lowest point of the year and now that the financial position is in order for the foreseeable future, the risk-return ratio seems to have improved to such an extent that speculative investors can consider an investment. According to the initial planning, the FDCA plant in Delfzijl should be operational by the end of 2023, but the misery on the labor market – combined with the sharp increase in inflation – threw a spanner in the works. Not only did the delivery date have to be postponed (to the second half of 2024), but additional financing was also needed. With the completion of the recent €70 million issue, the financing is now completely in place; management expects to have sufficient liquidity well beyond the moment that the plant will be operational. If the plant in Delfzijl is successfully operational in the second half of the year, management expects to be able to achieve a turnover of around €100 million in 2026, with the EBITDA coming in around zero. This means that from that moment on, no more money will be spent – ​​and Avantium therefore no longer needs to issue shares. In addition to two neutral recommendations, all other analysts have the share on “Buy”. The lowest and highest price targets are €2.40 and €9.57 respectively. The average price target is €5.24. Once the construction of the factory in Delfzijl is completed, it will be the first commercial FDCA factory in the world. If it succeeds before the end of the year, the share price will undoubtedly attract a lot of interest with sharply rising prices. Avantium has a market capitalization of only €170 million at the current price, but anyone who knows that the potential market is hundreds of billions also knows that there is a lot to be gained for the speculator. According to our expectation, the share price potential is between 100 and 400%, because if the FDCA factory in Delfzijl lives up to expectations, price targets of well above €10 can quickly be considered. We buy 1200 shares at €2.30 each.  Author has position

Lees verder >
Update

We bought Deceuninck for €2.27: Discover the latest developments

In this video, Rick van Zelst discusses Deceuninck stock, a leading company in the plastics sector. Sharesunderonetientje bought this stock at €2.27, and now it is around €2.45. Thanks to an optimized production process and signs of recovery in demand for plastics production, Deceuninck offers potential for significant margin improvement. Is this stock still worth it for your portfolio? Watch the video and judge for yourself!

Lees verder >
Update

Today we saw another increase on our top purchase, which now brings us towards a 25% profit.

HelloFresh (HELFY) saw a remarkable 13% rise on the Frankfurt stock exchange after announcing its second-quarter results that beat expectations. Despite a 3.1% drop in orders to 28.9 million and a 3.5% drop in meal deliveries to 243.8 million, the company still managed to impress. This was thanks to an impressive 5.4% increase in average order value to €67.10, which more than offset the volume declines. The Berlin-based company highlighted that this was the twelfth consecutive quarter of growth in average order value. This growth was mainly driven by a higher contribution from ready-to-eat products, an increase in premium and customizable meals, and a broader inclusion of market items. In addition, HelloFresh reduced price incentives in several product categories. HelloFresh also took significant steps to improve its production capacity, which however resulted in one-time, non-cash write-downs of €45 million in the first half of 2024, of which €32 million in the second quarter. Despite a 23% year-on-year decline in adjusted EBITDA to €146.4 million, the consensus estimate of €123 million was exceeded. Stocksunder100 see HelloFresh’s Ready-to-Eat (RTE) business performing strongly, now accounting for around a quarter of total group revenue. Free cash flow also remains strong, despite the second quarter historically being a period of lower volume. If you’ve already stocked up big, it may be wise to take a small portion of the profits. However, we believe the stock has even more potential and therefore choose to hold the full position.

Lees verder >